Post

New research · Nephrology
Annals of surgery · 2d
Cohort studyAnnals of surgery · 2026

Revisiting Simultaneous Liver and Kidney Transplantation from Donors After Circulatory Death in the Era of Machine Perfusion Technologies: A US Nationwide Analysis of 10,687 Cases.

Jiro Kusakabe, Eduardo Fernandes, Kalyan Ram Bhamidimarri … Antonio Pinna
Read paper
NephrologyCohort study

DCD donors now account for nearly one-third of all simultaneous liver-kidney transplants.

Revisiting Simultaneous Liver and Kidney Transplantation from Donors After Circulatory Death in the Era of Machine Perfusion Technologies: A US Nationwide Analysis of 10,687 Cases.

Jiro Kusakabe et al. · Annals of surgery · 2026
Background

Utilization of DCD donors for liver transplantation has increased substantially in the US, and MP and NRP were reported to reduce complications, including reperfusion syndrome and early allograft dysfunction.

Purpose

To evaluate national trends and clinical outcomes of donation after circulatory death (DCD) simultaneous liver-kidney transplantation (SLKT) in the US, particularly in the modern era following adoption of machine perfusion (MP) and normothermic regional perfusion (NRP).

Methods

Using UNOS STAR files, we analyzed 10.687 adult primary SLKT performed between 2000 and 2025.

29.3%
Results
nearly one-third of simultaneous liver-kidney transplants use donors whose hearts stopped
More results

In 2024, liver MP, kidney MP, and NRP were used in 58.1%, 82.9%, and 40.1% of DCD-SLKT cases.

Before matching, recipients in the DBD-SLKT group more frequently required dialysis at transplantation (69.1% vs 54.2%) and were hospitalized preoperatively (51.0% vs 17.2%), and had higher MELD scores (30 vs 23) during 2020-2025.

More results

Liver graft/patient survival were comparable between DCD- and DBD-SLKT regardless of PSM.

“
Conclusion · 1 of 2

Utilization of DCD donors for SLKT has increased substantially in parallel with the expanding use of MP and NRP, with graft/patient outcomes comparable to those of DBD-SLKT regardless of PSM.

Conclusion · 2 of 2

However, DBD-SLKT recipients had higher baseline preoperative risk. These support broader adoption of DCD donors for SLKT in appropriately selected recipients.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Guideline
almost 30%
people with VHL syndrome are affected by kidney cancer
Cohort Study
11.1%
hospitalizations for heart inflammation in dialysis patients that included severe heart issues
Cohort Study
hazard ratio 4.00
high genetic risk and severe CKM syndrome meant a much higher risk of knee arthritis
Cohort Study
OR = 0.220
belimumab was linked to a lower chance of lupus kidney disease symptoms returning
Cross-sectional
36%
Indian kidney doctors had no formal training in multiple myeloma